Moreover, the possible secretion of excess FGF23 from SaOS-2 cells suggests that overexpression not only affects intracellular pathways but also has paracrine effects, potentially influencing neighboring cells and contributing to the systemic nature of XLH. The gene discussed is FGF23; the disease is X-linked hypophosphatemia.